Univercells SA
- UEI
- WJ6AKEMYBDK6
- CAGE
- BTPN2
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Website
- univercells.com
- Founded
- 2013
- Employees
- 251-1K
- Estimated annual revenue
- $10M-$50M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
About Univercells SA
Univercells SA is a Belgium-based biotechnology company registered to receive federal contract awards from the U.S. government since July 27, 2018. As a corporate entity structured for profit, Univercells SA specializes in providing biomanufacturing solutions and services to support the development and production of biologics, including vaccines and cell and gene therapies. The company and its subsidiary, Univercells Technologies, offer a range of goods and services to federal agencies, primarily focused on bioreactor systems, cell culture technologies, and related equipment for biotechnology applications. Univercells SA's expertise lies in developing innovative platforms and technologies that aim to make biologics production more accessible and cost-effective.
Through its direct contract awards and subcontracts, Univercells SA and Univercells Technologies have supplied specialized bioreactor systems and associated consumables to U.S. federal agencies. Univercells Technologies has provided the Scale-X Carbo Cell Culture Bioreactor System and related consumables to the Department of Health and Human Services Food and Drug Administration (HHS/FDA). One such award, valued at $245,730.00 and completed in February 2021, was specifically tagged with a Coronavirus COVID-19 National Interest Action Code, indicating its relevance to pandemic response efforts. Additionally, Univercells Technologies has served as a subcontractor to Battelle Memorial Institute, supplying a Scale-X Hydro controller. Univercells SA itself has participated as a subcontractor to the International AIDS Vaccine Initiative Inc., contributing to a project focused on process development for cell culture and upstream and downstream processes in the production of HIV-related biomolecules. These contracts demonstrate the company's expertise in providing advanced biomanufacturing solutions for various biotechnology applications, including vaccine development and production. Notably, none of the prime contract awards to Univercells Technologies were set aside for specific business types, indicating that the company competes in full and open competition for federal contracts.
Quick answers
What is Univercells SA's UEI?
Univercells SA's Unique Entity ID (UEI) in SAM.gov is WJ6AKEMYBDK6.
What is Univercells SA's CAGE code?
Univercells SA's CAGE code is BTPN2.
What is Univercells SA's primary NAICS code?
Univercells SA's primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Is Univercells SA registered in SAM.gov?
Univercells SA's SAM.gov registration expired on November 1, 2021.
On GovTribe
See Univercells SA's full federal record
- Federal contract awards
- Subcontracting relationships
- Funding analysis by agency, NAICS and set-aside
- Similar vendors